Skip to content
Disclosery

ENAVATE SCIENCES GP, LLC: SION position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ENAVATE SCIENCES GP, LLC on SION, newest first. How the timeline and the estimate are built.

ENAVATE SCIENCES GP, LLC held 2,478,030 SION shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,478,030 shares
    Change vs previous 13F 0 shares

    31.56% of the 13F portfolio, value $109,008,540.

    13F-HR 0001953107-26-000012 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,478,030 shares
    Change vs previous 13F 0 shares

    28.26% of the 13F portfolio, value $99,344,223.

    13F-HR 0001953107-26-000008 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,478,030 shares
    Change vs previous 13F 0 shares

    20.12% of the 13F portfolio, value $101,946,154.

    13F-HR 0001953107-26-000003 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,478,030 shares
    Change vs previous 13F 0 shares

    22.25% of the 13F portfolio, value $72,878,862.

    13F-HR 0001953107-25-000014 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,478,030 shares
    Change vs previous 13F 0 shares

    24.35% of the 13F portfolio, value $42,993,821.

    13F-HR 0001415889-25-021852 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,478,030 shares
    Change vs previous 13F not available

    19.53% of the 13F portfolio, value $25,920,194.

    13F-HR 0001415889-25-013132 filed by ENAVATE SCIENCES GP, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).